A study to understand the patients point of view (anxiety level and pain score) undergoing bone marrow first time, the total cost spent towards bone marrow procedure and benefit of the Tramadol in controlling pain if given along with the local anesthesia during bone marrow procedure.
Phase 3
- Conditions
- Health Condition 1: C910- Acute lymphoblastic leukemia [ALL]Health Condition 2: C920- Acute myeloblastic leukemiaHealth Condition 3: C919- Lymphoid leukemia, unspecifiedHealth Condition 4: C929- Myeloid leukemia, unspecifiedHealth Condition 5: C96Z- Other specified malignant neoplasms of lymphoid, hematopoietic and related tissue
- Registration Number
- CTRI/2024/01/062117
- Lead Sponsor
- Tata Memorial Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Age Criteria: 15 Years or older
Patients who have been planned to undergo BMAB at our center (at diagnosis or response
assessment)
Exclusion Criteria
Patients refusing to give informed consent for BMAB procedure or for the study.
Patients who have received premedication with any sedative, analgesic or any other CNS depressant,
30 min before the BMAB or ongoing use of these drugs.
Patients who are on Carbamazepine, a hepatic enzyme inducer.
History of opioid dependency or addiction.
Known cases of allergy or hypersensitivity with use of opioids.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method